← Back to Search

Molecular Diagnostics

Rapid POC Diagnostics for Strep Throat

N/A
Waitlist Available
Research Sponsored by Hamilton Health Sciences Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at enrolment
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing how effective a rapid point-of-care molecular GAS diagnostics is compared to standard culture-based techniques for diagnosing children aged 3-18 years of age with a sore throat.

Who is the study for?
This trial is for children aged 3-18 who visit the McMaster Children's Hospital Emergency Department with a sore throat and need a GAS test. They can't have taken antibiotics effective against GAS in the last 72 hours.
What is being tested?
The study compares rapid point-of-care molecular diagnostics for strep throat with standard culture-based tests to see which is more effective in diagnosing and managing the condition quickly.
What are the potential side effects?
There are generally no side effects associated with these diagnostic tests, but there may be minor discomfort or gagging during the throat swab procedure.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at enrolment
This trial's timeline: 3 weeks for screening, Varies for treatment, and at enrolment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Appropriate antibiotic treatment
Secondary study objectives
Caregiver satisfaction with testing
ED MD satisfaction with testing
Time required to utilize point-of-care testing

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Rapid testingExperimental Treatment1 Intervention
Abbott ID NOW Strep A testing.
Group II: Reference testingActive Control1 Intervention
Culture-based testing.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Rapid testing
2021
N/A
~1400

Find a Location

Who is running the clinical trial?

Hamilton Health Sciences CorporationLead Sponsor
377 Previous Clinical Trials
339,537 Total Patients Enrolled

Media Library

Rapid testing (Molecular Diagnostics) Clinical Trial Eligibility Overview. Trial Name: NCT04247243 — N/A
Strep Throat Research Study Groups: Reference testing, Rapid testing
Strep Throat Clinical Trial 2023: Rapid testing Highlights & Side Effects. Trial Name: NCT04247243 — N/A
Rapid testing (Molecular Diagnostics) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04247243 — N/A
~80 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top